View Press Releases

Rho to Use Clinical Trial Oversight Summit as Platform to Share Best Practices in Clinical Monitoring

May 27, 2014
Clinical trial thought leaders share insight on risk-based monitoring, monitoring with EDC, and the importance of strong relationships between sites and CROs

CHAPEL HILL, NC, UNITED STATES - May 28, 2014 - Rho to Use Clinical Trial Oversight Summit

as Platform to Share Best Practices in Clinical Monitoring

Clinical trial thought leaders share insight on risk-based monitoring, monitoring with EDC, and the importance of strong relationships between sites and CROs

 

WHAT:          Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced its participation at the 5th Annual Clinical Oversight Summit in Boston as a sponsor.

                       

                        With more than 35 years in clinical research, Rho clinical operations expert Gail Fowler will join Rho senior project manager, Emily Cantrell, to provide valuable thought leadership on topics including risk-based monitoring, monitoring using EDC, and building relationships with sites.  

 

WHO:             Rho experts available for interview at the Clinical Trial Oversight Summit, upon request:

  • Gail Fowler, vice president of operations, Rho
  • Emily Cantrell, senior project manager, Rho

 

WHEN:          June 2-3, 2014

 

WHERE:       Hilton Boston Back Bay

                   40 Dalton St.

                        Boston, MA 02115    

DETAILS:     For media inquiries or to arrange an interview with Gail Fowler or Emily Cantrell, please contact Jessica Highsmith at Largemouth Communications, (919) 459-6456, jessica@largemouthpr.com.

 

ABOUT:        Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For 30 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Twitter

###